• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

CalmiGo Donates Exhalers to Help Survivors of Terrorist Attacks in Israel Cope with Anxiety and PTSD

by Syed Hamza Sohail 11/13/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

  • CalmiGo, a developer of the first and only drug-free device that empowers people suffering from anxiety, PTSD, and panic attacks with immediate relief, announces that the company donated 1200 portable exhalers to the victims of the terrorist attacks in Israel to help calm anxiety and alleviate symptoms of PTSD.
  • The donations were made possible due to the help of the non-profit organization, Reim, that provides urgent medical aid to Israel, as well as other generous donors.

Helping Civilians Cope with PTSD

Currently, numerous individuals throughout Israel are experiencing extreme anxiety and trauma from the attacks and there is a country-wide shortage of mental health professionals to address these sudden conditions. In an effort to assist the country recover emotionally from the attacks, CalmiGo is aiming to distribute their devices by using a triage method along with collaborating with healthcare professionals to ensure those most impacted receive the devices first.

Because of the shortage of healthcare professionals, drug-free devices aimed to relieve anxiety are invaluable to the recovery process of the victims since it does not require constant evaluation by a therapist, as medication mandates.

CalmiGo, a company with offices in New York and Israel, developed a scientifically proven and drug-free device that empowers people of all ages suffering from anxiety, stress, PTSD, or panic attacks to effortlessly manage their symptoms. The CalmiGo device is developed with patented technology that combines sensors and machine learning to learn a users’ breathing patterns in real time. The device provides guidance and feedback to help extend the length of exhalation between breathing cycles to activate the parasympathetic system, which counteracts the “fight or flight” response that one experiences in an anxiety attack. The device also incorporates grounding, a scientifically proven technique for treating anxiety and trauma, that involves activating four senses: sight, smell, sound, and touch. It does this with light cues to regulate breathing, embedded scents, as well as vibration.

“In light of the surge in anxiety and trauma cases in Israel right now, we wanted to make sure that we sent our devices to Israel to provide relief and intervention as soon as possible to those who are suffering,” says Adi Wallach, Chief Executive Officer at CalmiGo. ““To reduce the severity of symptoms in the long term, we know that it is critical to provide intervention as soon as possible after a traumatic event. With the help of our donors we are able to send our devices there shortly after the attacks. Our hearts are with all of the victims during this time.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

Digital Health Funding Q3 2025: Choppy Undercurrents Beneath a Steady Surface

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Oracle Confirms Layoffs in Kansas City

Oracle Confirms Layoffs in Kansas City

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Philips Future Health Index 2025: AI and Digital Tech Can Help Solve Cardiac Care Crisis

Optain Health Secures $26M to Advance AI-Powered Retinal Screening

Optain Health Secures $26M for AI-Powered Retinal Screening

Sutter Health and Epic Launch "Sutter Sync" to Optimize Remote Chronic Care

Sutter Health and Epic Launch “Sutter Sync” to Optimize Remote Chronic Care

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |